7-Nitro-3-(thiophen-2-yl)quinoxalin-2(1H)-one | 832081-87-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 7-Nitro-3-(thiophen-2-yl)quinoxalin-2(1H)-one
• 英文别名: 7-nitro-3-thiophen-2-yl-1H-quinoxalin-2-one
• CAS: 832081-87-5
• 化学式: C₁₂H₇N₃O₃S
• 分子量: 273.272
• InChiKey: RYQSXSRRMAQANK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  116
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  氧代(2-噻吩基)乙酰氯 、 4-硝基邻苯二胺 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以70%的产率得到7-Nitro-3-(thiophen-2-yl)quinoxalin-2(1H)-one
  参考文献：
  名称：

  Synthesis of unsymmetrical and regio-defined 2,3,6-quinoxaline and 2,3,7-pyridopyrazine derivatives

  摘要：

  Differential reactivity of the amine functionality in a number of common 1,2-diamine starting materials is exploited to undertake an expedient synthesis of unsymmetrical 2,3,6-trisubstituted quinoxaline and unsymmetrical 2,3,7-trisubstituted pyridopyrazine derivatives. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2007.10.117

文献信息

• [EN] PKB INHIBITORS AS ANTI-TUMOR AGENTS<br/>[FR] INHIBITEURS DE LA PKB UTILISES COMME AGENTS ANTITUMORAUX
  申请人：IMCLONE SYSTEMS INC

  公开号：WO2005007099A2

  公开（公告）日：2005-01-27

  The invention is directed to biaryl compounds with two six membered rings fused wherein at least one six membered ring is substituted with a thiophenyl or furanyl ring. Useful in the inhibition of PKB kinase, the treatment of cancer, or the inhibition of tumor growth.
• Synthesis of unsymmetrical and regio-defined 2,3,6-quinoxaline and 2,3,7-pyridopyrazine derivatives
  作者：Dan Sherman、Joel Kawakami、Hai-Ying He、Farah Dhun、Raphael Rios、Hu Liu、Weitao Pan、Yong-Jiang Xu、Sang-phyo Hong、Melissa Arbour、Marc Labelle、Matthew A.J. Duncton

  DOI：10.1016/j.tetlet.2007.10.117

  日期：2007.12

  Differential reactivity of the amine functionality in a number of common 1,2-diamine starting materials is exploited to undertake an expedient synthesis of unsymmetrical 2,3,6-trisubstituted quinoxaline and unsymmetrical 2,3,7-trisubstituted pyridopyrazine derivatives. (c) 2007 Elsevier Ltd. All rights reserved.